Masonic Cancer Center Articles


Masonic Cancer Center Clinical Trials

As one of only 51 NCI-Designated comprehensive cancer centers throughout the United States, the Masonic Cancer Center, University Minnesota’s mission is to serve the people of Minnesota and to put our energy and skills towards ending the…

NCI-designated cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track

The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention. Today, doctors and scientists across America at National Cancer Institute (NCI)-…
ctd 2021

Clinical Trials Day 2021

Happy Clinical Trials Day! Today is a day to celebrate those who conduct and participate in clinical research. Hear from the MNCCTN HUB, partners, and site staff about why we love working in research and how research creates impact.

Dr. Jeffrey Miller Awarded $9M NIH/NCI P01 Program Project Grant to Develop Off-The-Shelf NK Cells

MINNEAPOLIS/ST. PAUL — Jeffrey Miller, MD, Deputy Director of the Masonic Cancer Center, and his research team have been awarded a $9M National Institutes of Health (NIH) P01 Program Project Grant grant from the National Cancer Institute (…